Listed

Edwards Lifesciences Corp

EWNYSECIK 1099800HealthcareFiscal year ends Dec 31

Reports and events: 240 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Edwards Lifesciences Corp, Reports and events
FiledFormWhat it isAccession number
2023-04-2616:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-23-000019
2023-03-2816:16 ETDEF 14AProxy statement0001099800-23-000013
2023-02-2116:30 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-23-043538
2023-02-1316:32 ET10-KAnnual reportPeriod 2022-12-310001099800-23-000005
2023-01-3116:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-23-000003
2022-12-0817:27 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-301136
2022-11-0109:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-274553
2022-10-2816:21 ET10-QQuarterly reportPeriod 2022-09-300001099800-22-000025
2022-10-2716:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-22-000023
2022-07-2916:55 ET10-QQuarterly reportPeriod 2022-06-300001099800-22-000020
2022-07-2816:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-22-000016
2022-07-2116:20 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-22-199173
2022-05-0417:19 ET8-K5.07 Shareholder vote results0001193125-22-140622
2022-04-2816:08 ET10-QQuarterly reportPeriod 2022-03-310001099800-22-000009
2022-04-2616:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-22-000007
2022-03-2216:02 ETDEF 14AProxy statementPeriod 2022-05-030001193125-22-081590
2022-02-1416:15 ET10-KAnnual reportPeriod 2021-12-310001099800-22-000005
2022-01-2616:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-22-000002
2021-10-2916:56 ET10-QQuarterly reportPeriod 2021-09-300001099800-21-000027
2021-10-2716:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-21-000024
2021-07-3016:06 ET10-QQuarterly reportPeriod 2021-06-300001099800-21-000022
2021-07-2916:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-21-000020
2021-07-1517:14 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-216533
2021-05-0516:56 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-151848
2021-04-2816:09 ET10-QQuarterly reportPeriod 2021-03-310001099800-21-000012
2021-04-2016:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-21-000010
2021-03-2316:14 ETDEF 14AProxy statementPeriod 2021-05-040001193125-21-091192
2021-02-1216:58 ET10-KAnnual reportPeriod 2020-12-310001099800-21-000007
2021-01-2716:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-21-000004
2020-10-2619:57 ET10-QQuarterly reportPeriod 2020-09-300001099800-20-000024
2020-10-2217:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-20-000022
2020-07-2716:55 ET10-QQuarterly reportPeriod 2020-06-300001099800-20-000019
2020-07-2316:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-20-000017
2020-07-1508:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-193022
2020-07-1316:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-191882
2020-05-0816:26 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-137597
2020-04-2819:56 ET10-QQuarterly reportPeriod 2020-03-310001099800-20-000009
2020-04-2316:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-20-000007
2020-03-2516:16 ETDEF 14AProxy statementPeriod 2020-05-070001193125-20-085079
2020-02-1416:13 ET10-KAnnual reportPeriod 2019-12-310001099800-20-000005
2020-01-3016:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-20-000002
2019-10-2516:08 ET10-QQuarterly reportPeriod 2019-09-300001099800-19-000024
2019-10-2316:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-19-000022
2019-07-2616:05 ET10-QQuarterly reportPeriod 2019-06-300001099800-19-000019
2019-07-2316:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-19-000017
2019-05-0817:30 ET8-K5.07 Shareholder vote results; 8.01 Other events0001193125-19-141632
2019-04-2616:09 ET10-QQuarterly reportPeriod 2019-03-310001099800-19-000011
2019-04-2316:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001099800-19-000008
2019-03-2716:25 ETDEF 14AProxy statementPeriod 2019-05-080001193125-19-088534
2019-02-1516:22 ET10-KAnnual reportPeriod 2018-12-310001099800-19-000004

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 03:19 ET. Listed shows no prices and gives no investment advice.